SENTI BIOSCIENCES, INC.

Analyst Reco. Senti Biosciences, Inc.

Equities

SNTI

US81726A1007

End-of-day quote Nasdaq Other stock markets 03:30:00 25/04/2024 am IST			5-day change	1st Jan Change
0.2787 ^USD	-0.78%		-9.37%	-57.77%

26/04	Senti Biosciences, Inc. Announces Resignation of Deborah Knobelman as Chief Financial Officer, Effective May 3, 2024	CI
26/04	Senti Biosciences, Inc. Announces Resignation of Deborah Knobelman as Treasurer and Head of Corporate Development, Effective May 3, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Cuts Price Target on Senti Biosciences to $6 From $7, Keeps Buy Rating	11/23/11	MT
Morgan Stanley Adjusts Price Target on Senti Biosciences to $2 From $3, Keeps Equalweight Rating	24/23/24	MT
Chardan Adjusts Price Target on Senti Biosciences to $7 From $8, Keeps Buy Rating	23/23/23	MT
Chardan Adjusts Senti Biosciences' Price Target to $8 From $12, Keeps Buy Rating	30/23/30	MT
JPMorgan Initiates Coverage on Senti Biosciences With Neutral Rating	16/22/16	MT
Morgan Stanley Starts Senti Biosciences at Equalweight With $7.50 Price Target	07/22/07	MT
BofA Securities Starts Senti Biosciences at Buy With $7 Price Target	29/22/29	MT
Chardan Research Initiates Senti Biosciences With Buy Rating, $12 Price Target; Shares Climb 12% After Hours	23/22/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer